Form 8-K - Current report:
SEC Accession No. 0001437749-23-027858
Filing Date
2023-10-06
Accepted
2023-10-06 16:20:20
Documents
15
Period of Report
2023-10-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dyai20231004_8k.htm   iXBRL 8-K 27657
2 EXHIBIT 99.1 ex_576718.htm EX-99.1 20484
7 dyad.jpg GRAPHIC 2856
  Complete submission text file 0001437749-23-027858.txt   190419

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dyai-20231005.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dyai-20231005_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyai-20231005_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyai-20231005_pre.xml EX-101.PRE 11584
9 EXTRACTED XBRL INSTANCE DOCUMENT dyai20231004_8k_htm.xml XML 2571
Mailing Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477
Business Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32513 | Film No.: 231314441
SIC: 2836 Biological Products, (No Diagnostic Substances)